Literature DB >> 29801664

Choosing Front-line Treatment for Metastatic Renal Cancer: Which Data Are Meaningful?

Tom Powles1.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29801664     DOI： 10.1016/j.eururo.2018.05.001

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  1 in total

1.  Combining Immune Checkpoint and VEGFR Inhibition in Favorable Risk and Elderly Patients With Metastatic Renal Cell Carcinoma.

Authors:  Andreas Varkaris; Wenxin Xu; Roger B Davis; Brian Healy; David F McDermott
Journal:  Clin Genitourin Cancer       Date:  2019-12-05       Impact factor: 2.872
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.